Safety and Immunogenicity of Fluzone Quadrivalent Vaccine Administered to Healthy Children 6 Months to 36 Months of Age

Investigator: Klein, Nicola

Funder: Sanofi Pasteur S.A.

Explore all studies and publications

Back To Top